Atlas Trials

Recurrent Malignant Testicular Germ Cell Tumor

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Malignant Testicular Germ Cell Tumor

RecordFirmDate
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors (NCT01808534)Indiana University2013-02-01
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant (NCT01558778)Roswell Park Cancer Institute2012-05-01
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant (NCT01305200)Children's Oncology Group2011-03-01
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload (NCT01159067)City of Hope Medical Center2010-07-01
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790)Abramson Cancer Center at Penn Medicine2009-10-01
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant (NCT00795769)Fred Hutchinson Cancer Center2008-08-08
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors (NCT00467051)Children's Oncology Group2007-11-05
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898)City of Hope Medical Center2007-02-26
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00536601)Roswell Park Cancer Institute2006-06-29
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant (NCT00408681)Fred Hutchinson Cancer Center2006-06-01
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer (NCT00060372)National Cancer Institute (NCI)2003-04-01
Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer (NCT00042952)National Cancer Institute (NCI)2002-06-01
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496)National Cancer Institute (NCI)2001-11-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Recurrent Malignant Testicular Germ Cell Tumor automatically

Every clearance here is in the API, with alerts when new ones post.